NextCure Inc banner

Intrinsic Value

Not Available for NXTC

There is not enough data to reliably calculate the intrinsic value for NextCure Inc.

Do our valuations actually work? See backtest results .

Alternatives to NXTC

Fundamental Analysis

What NextCure Does

Biotechnology Health Care

NextCure is a clinical-stage biotechnology company that discovers and develops antibody-based drugs for cancer and other serious diseases. Its main work is to find immune-system targets that can be used to help the body fight tumors, then turn those targets into drug candidates that can be tested in patients. The company does not sell consumer products; it sells science and drug development programs.

Headquarters
United States of America US
Employees
40
IPO date
May 9, 2019
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
NextCure Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

NXTC Insider Trading
Buy and sell transactions by insiders